Baxter Bros’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
– Sell
-9,590
Closed -$231K – 121
2017
Q2
$231K Buy
+9,590
New +$210K 0.07% 110

Other funds holding PGEN

Baxter Bros's PGEN Position: Q3 2017 in Review

Baxter Bros sold out of Precigen (PGEN) in Q3 2017, closing a stake of 9,590 shares — an estimated $231K sold.

Baxter Bros first reported a position in PGEN in Q2 2017 and held it in 1 quarter. The position peaked at $231K in Q2 2017. 155 funds tracked by Wall St. Rank hold PGEN as of Q3 2017.

  • Baxter Bros reported no remaining Precigen position as of Q3 2017 after selling out during the quarter.
  • Baxter Bros sold 9,590 Precigen shares in Q3 2017, an estimated $231K.
  • Baxter Bros first reported a position in Precigen in Q2 2017 and held it in 1 quarter.
  • Baxter Bros's Precigen position peaked at $231K in Q2 2017.
  • 155 funds tracked by Wall St. Rank held Precigen as of Q3 2017.

Based on Baxter Bros's 13F filing for Q3 2017, filed 16 Oct 2017.